(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACENTRUS SPECIALTY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ACENTRUS SPECIALTY

ST13

US500000087686450

Class

35, 36

Filing

87686450

Registration

6211485

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

12/02/2025

Classification

Registered

Trademark type

Word

Nice classes

35, 36

Filing date

11/15/2017

Registration date

12/01/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/01/2020

Last transaction

12/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/04/2017

First use in commerce

12/04/2017

Drawing code

4

Owner type

03

Owner location

Irving, TX

Examiner

LEASER,ANDREW C

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vizient, Inc.

Representatives

Todd C. Basile GREENBERG TRAURIG LLP

Technical classification

Nice Classes

Class 35Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business administrationinformation and management services of pharmacy and specialty pharmacy drug programs for health care systemsdrug manufacturerspharmacy benefit managersmedical and pharmaceutical consultantsinsurance and drug distribution companies; business administration and management of pharmacy and specialty pharmacy reimbursement programs and services; pharmaceutical procurement servicespharmaceutical cost management services and drug utilization review services; providing businesspricingreimbursement benchmarking and other market intelligence information in the field of drug reimbursement for health care systemsprescribers and the pharmaceutical industry; promoting collaboration within the medicalscientific and research communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving specialty drug and pharmacy solutions; providing purchase pricing information of pharmacy and specialty pharmaceuticals for health care systems

Class 36

Financial administrationinformationmanagementtracking and reporting services of pharmacy and specialty pharmacy drug programs for health care systems; financial administration and management of pharmacy reimbursement programs and services; and financial clearinghouse and research servicesproviding financial research of pharmacy and specialty pharmaceuticals for health care systems

Publications

History of USPTO decisions and trademark events.

46 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/01/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/22/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/01/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/28/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/27/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/08/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/07/2020

EX3G

SOU EXTENSION 3 GRANTED

10/07/2020

IUAF

USE AMENDMENT FILED

09/30/2020

EXT3

SOU EXTENSION 3 FILED

09/30/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/30/2020

EISU

TEAS STATEMENT OF USE RECEIVED

09/30/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/08/2020

EX2G

SOU EXTENSION 2 GRANTED

04/07/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/07/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/06/2020

EXT2

SOU EXTENSION 2 FILED

04/02/2020

EEXT

SOU TEAS EXTENSION RECEIVED

04/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/01/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/01/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/01/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/01/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/01/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/01/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/04/2019

EX1G

SOU EXTENSION 1 GRANTED

10/02/2019

EXT1

SOU EXTENSION 1 FILED

10/02/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/02/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/02/2019

TMBN

TTAB RELEASE CASE TO TRADEMARKS

02/19/2019

OP.T

OPPOSITION TERMINATED NO. 999999

02/19/2019

OP.D

OPPOSITION DISMISSED NO. 999999

02/19/2019

OP.I

OPPOSITION INSTITUTED NO. 999999

10/15/2018

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

05/17/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/17/2018

PUBO

PUBLISHED FOR OPPOSITION

04/17/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/28/2018

ALIE

ASSIGNED TO LIE

03/15/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/06/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

03/06/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/06/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

03/06/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/06/2018

DOCK

ASSIGNED TO EXAMINER

02/27/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/29/2017

NWAP

NEW APPLICATION ENTERED

11/18/2017

Continuous trademark protection

Get notified about every new filing that threatens ACENTRUS SPECIALTY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.